Profile: Bioalvo is a drug development company, that focuses on central nervous system disorders. We design and develop drug screening platforms that generate potent and efficient drugs, aimed at building successful therapies. We specialize in the research lead drug discovery process and in the early preclinical phase of the drug development process. Our main strategy is to develop projects, from the exploratory research phase, until the end of the preclinical stage. Our expertise in the molecular field, and an entirely new discovery strategy & technological approach allow us to offer solutions at these specific phases of the drug development & production processes.